Internal Medicine Alert – November 30, 2003
November 30, 2003
View Issues
-
Insurance Administrators, Take Note!
Sleepiness, obesity, hypertension, witnessed apneas, and frequent snoring are prevalent in the general population; demand for diagnostic and treatment services for sleep apnea is likely to skyrocket. -
The Longer You Stay, the Longer You Stay
Like patients hospitalized with acute myocardial infarction and total knee replacements, EM of hospitalized patients with CAP reduces overall hospital length of stay and institutional resources without increasing the risk of adverse outcomes. -
Duration of Antiviral Immunity After Smallpox Vaccination
More than 90% of individuals studied maintain measurable humoral or T-cell-mediated immunity against vaccinia virus for as long as 75 years after smallpox vaccination. -
Do You Know the Difference Between Impaired Fasting Glucose and Impaired Glucose Tolerance?
The new criterion for FPG will identify many more individuals who are at risk for developing diabetes. -
Pharmacology Update: Daptomycin Injection (Cubicin)
The FDA has approved the first of a new class of antibiotics for the treatment of complicated skin and skin structure infections. Daptomycin is a cyclic lipopeptide that is active against Gram-positive bacteria. -
Clinical Briefs
St Johns Wort and Drug Interactions; Serum Potassium and Stroke Risk Among Hypertensive Adults; Skin Cancer Prevention and Detection Practices Among Siblings of Patients with Melanoma